Home > News > Headline News


Please Note

Some news stories may require you to register or sign in.  MedPage, for example, has an easy and free subscription form that only needs to be completed once--well worth the effort to access their timely and important articles.

Click on title to read the full article.

Algeta announces positive preliminary bone marker results in a phase IIa study evaluating Alpharadin in breast cancer patients w

June 7, 2020

A company focused on the development of novel targeted cancer therapeutics, today announced that preliminary data from its phase IIa study of Alpharadin (radium-223 chloride) for the treatment of bone metastases in 23 patients with endocrine-refractory breast cancer showed positive results for bone markers.

NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer

June 4, 2020

By Herald Online

Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 as a second- and third-line treatment in patients with metastatic breast cancer during the 2011 American Society of Clinical Oncology Meeting (ASCO).

Diabetes drug may have cancer use

June 3, 2020

A class of diabetes drugs may activate a protein found to decrease malignancy and slow the spread of some breast cancer tumors, a Canadian researcher says.

Complementary Cancer Treatments: Which Is For You?

June 3, 2020

By Joseph Nowinski, PhD

This was a study of women with metastatic breast cancer -- cancer that has spread from the breast to other organs. There is little doubt that these women were under chronic stress, even if they were able to continue functioning in their daily lives. It was found that the more symptoms of depression these women had, the less their immune systems were able to respond to a variety of bacteria, fungi and yeasts.

Study Evaluating SIR-Spheres® Microspheres in Patients with Metastatic Breast Cancer Presented at the 2011 American Society of C

June 3, 2020

Sirtex, a leading developer and manufacturer of targeted, innovative liver cancer therapies, today announced the results of a five-year study evaluating the tolerability, efficacy and survival rates of Selective Internal Radiation Therapy (SIRT), also known as radioembolization, using SIR-Spheres® microspheres in patients with liver metastases from breast cancer that are refractory to chemotherapy. The study was led by Roberto Cianni, M.D., interventional radiologist at Santa Maria Goretti Hospital in Latina, Italy.

In the Pipeline: Cabozantinib Shown to Control Tumors and Bone Metastases

May 22, 2020

By Jennie Smith

The experimental drug cabozantinib achieved high rates of disease control and shrunk or eliminated bone metastases in a range of advanced cancers, according to results from a phase II trial.

Blood Test For Breast Cancer?

May 22, 2020

Researchers at Georgetown Lombardi Comprehensive Cancer Center say the amount of circulating tumor cells (CTCs) in the blood is a "powerful predictor" and reliable for aiding physicians when they assess treatment benefit for patients with metastatic breast cancer.

Nexavar In Combination With Chemotherapy Improves Progression-Free Survival In Patients With Advanced Breast Cancer In Phase 2 S

May 22, 2020

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced results from a Phase 2b trial evaluating Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic breast cancer

Genentech Appeals to FDAs Regulatory Flexibility on Avastin

May 18, 2020

By Mary Jo Laffler

Genentech’s advance summary of evidence and arguments for the Food and Drug Administration’s upcoming hearing on the agency’s proposed withdrawal of the metastatic breast cancer approval for Avastin shows that the company is trying to keep the focus on the additional confirmatory trial it proposes to conduct.

Should a Mother Lose Custody of Her Kids Because She Has Cancer?

May 12, 2020

By Bonnie Rochman

Alaina Giordano was already engaged in a battle royale, fighting Stage 4 breast cancer, when her struggle intensified recently: a judge ruled that the N.C. woman must give up custody of her two children to her husband, who lives in Chicago, in part because "children who have a parent with cancer need more contact with the non-ill parent."